Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Guidelines
What's New in the 2011 ACCF/AHA Guidelines?
Featured Articles
Is it Time for Antiplatelet Therapy to Enter Personalized Medicine?
Clinical Trial Highlights
TAVR is Noninferior to Surgical AVR in High-Risk Patients with Aortic Stenosis: Results from the PARTNER Trial
Results from the Randomized PARTNER Trial (Cohort B)
One-Year Data from the RESOLUTE US Trial
The PLATINUM Trial: New Metal Alloy DES is Similar to a Predicate DES for Uncomplicated Elective PCI
The RAPS Trial: Radial Artery Grafts are Associated with Greater Longer-Term Patency than SVGs
Radial Access is Not Superior to Femoral Access for Coronary Angiography or Intervention in Patients with ACS
EVEREST Trial 2-Year Results Show Stability of Percutaneous MV Repair between Years 1 and 2
Targeted LV Lead Placement is Feasible and Associated with Enhanced CRT Response
Comparison of 6 and 12 Months of DAT after Implantation of a DES
No Mortality Benefit from CABG When Added to Optimal Medical Therapy in Patients with CAD and LV Dysfunction: Results from the STICH Trial
Myocardial Viability Does Not Predict Survival Benefit after CABG
DES Reduce the Need for Repeat Revascularization: Results from the ISAR-CABG Trial
Preventing Contrast-Induced Acute Kidney Injury: Results from the REMEDIAL Trial ll
Selected Updates
Innovations in Cardiovascular Devices Will Offer Potential Benefits as Well as Challenges
Emerging Evidence of Intensive Risk Factor Control to Prevent CVD in Diabetic Patients
Selected Updates in Heart Failure
Systems of Care are Integral to Improving STEMI Treatment
Other Peer-Reviewed Articles
Vitamin D and the Heart
A Look into the Future: Elinogrel, Cangrelor, PAR Antagonists, and Aptamers
Back to top
Previous
Next
Search for this keyword